Found 9 results
Author Title Type [ Year(Asc)]
Filters: Author is Stablein, Don  [Clear All Filters]
2018
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
2016
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.”, Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
2013
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., “Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.”, Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.
2012
M. L. Robb, Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., Paris, R. M., Chiu, J., Adams, E., Francis, D., Gurunathan, S., Tartaglia, J., Gilbert, P., Stablein, D., Michael, N. L., and Kim, J. H., “Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.”, Lancet Infect Dis, vol. 12, no. 7, pp. 531-7, 2012.
2011
S. Nguyen, Martz, K., Stablein, D., and Neu, A., “Wait list status of pediatric dialysis patients in North America.”, Pediatr Transplant, vol. 15, no. 4, pp. 376-83, 2011.
2010
B. S. Graham, M McElrath, J., Keefer, M. C., Rybczyk, K., Berger, D., Weinhold, K. J., Ottinger, J., Ferarri, G., Montefiori, D. C., Stablein, D., Smith, C., Ginsberg, R., Eldridge, J., Duerr, A., Fast, P., and Haynes, B. F., “Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.”, PLoS One, vol. 5, no. 8, p. e11995, 2010.
2004
S. C. Jordan, Tyan, D., Stablein, D., McIntosh, M., Rose, S., Vo, A., Toyoda, M., Davis, C., Shapiro, R., Adey, D., Milliner, D., Graff, R., Steiner, R., Ciancio, G., Sahney, S., and Light, J., “Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.”, J Am Soc Nephrol, vol. 15, no. 12, pp. 3256-62, 2004.
2003
D. J. Weisdorf, Hurd, D., Carter, S., Howe, C., Jensen, L. Ann, Wagner, J., Stablein, D., Thompson, J., and Kernan, N. A., “Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.”, Biol Blood Marrow Transplant, vol. 9, no. 8, pp. 512-8, 2003.
2002
S. L. Furth, Stablein, D., Fine, R. N., Powe, N. R., and Fivush, B. A., “Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatrics, vol. 109, no. 5, pp. 909-13, 2002.